many services

one goal

About us

History

Innovation in Pharmacology

InnoPharma: a full service CRO based in the Milan area.

Since 1995, we meet the toughest challenges in the pharmaceutical, devices and biotechnology development sector.

Our group has the capability and expertise to manage national and international clinical trials and to provide development services either in-house or as part of integrated solutions supporting clients in accelerating time-to-market, control development costs and reducing risks on investment costs.

We provide services to some of the leading Pharmaceutical and Biotech companies, helping them develop and launch some of the most important drugs of our time by providing a centralized management approach to help ensure consistency for big European trials and multicenter research.

Meet the Team

Massimiliano Stasi, MD – General Manager, President and CEO

Massimiliano is a certified Medical Doctor and Surgeon in cardiology with 30+ years of clinical research experience in both pharmaceutical and CROs environments.

He has co-founded InnoPharma in 1995 and since 2006 he is owner and General Manager and he oversees all client relationships. As a hands-on manager, Massimiliano, with his in-depth exerience and knowledge, is a resource for the whole clinical team, providing guidance and resolution on an ongoing basis, through frequent meetings and direct communication with the InnoPharma’s staff.

Marco Caimi – Project Management Director    

Marco has a Bachelor Degree in Biology with a master in Biology applied to medical research and has solid clinical research experience of more than 15 years. With his experience, passion and attention, Marco supervises and coordinates the Clinical Project Manager team to ensure that sponsors are provided with the best scientific, regulatory and operational support. Through frequent meetings and contacts with his team, he ensures a proactive identification and quick management of projects’ risks and issues.

Roberto Trabattoni – Clinical Monitoring Director           

Roberto has a Bachelor Degree in Biotechnology with medical address, and with his extensive clinical experience in CRO environments he has spent the past 10 years as a Lead CRA/CRA Coordinator/Clinical Monitoring Director for InnoPharma. In this role, he successfully manages CRAs in both EU and non EU countries, overseeing the teams for all projects’ duration.

As a young and talented Clinical Monitoring Director, he selects his team of CRAs, ensuring that productivity and competency levels are maximised and  that the training needs are satisfied, with constant attention to quality and timelines.

Alessandra Bertani – Regulatory Affairs Director              

Alessandra is a certified biologist and has 30+ years of experience in healthcare settings, a master in Regulatory Affairs and has worked both in global pharmaceutical environment and CROs.

Since the early 2000, she manages Innopharma’s Study Start-up and Regulatory team and oversights the submission phase for each study, with an extensive expertise in EU and non EU countries in each clinical study phase.

Alessandra provides know-how and training to the regulatory team, and a constant update on new norms and regulations on clinical trials with drugs and devices.

Through years of dedication, she has grown a passionate, supportive and hardworking team.

Carlotta Cozzi – Quality Assurance Manager    

Carlotta has nearly 13 years of experience in clinical research and over 15 years of experience of quality management in accordance with GCP.

She is Head of the Quality Assurance unit of InnoPharma. Quality Assurance Unit manages the Quality assurance system, Audit and Training activities in accordance with applicable regulations and GCPs.

Carlotta works closely with other units to ensure their results are of a high standard.

  • GM and administration

  • Massimiliano Stasi, MD – General Manager, President and CEO

    Massimiliano is a certified Medical Doctor and Surgeon in cardiology with 30+ years of clinical research experience in both pharmaceutical and CROs environments.

    He has co-founded InnoPharma in 1995 and since 2006 he is owner and General Manager and he oversees all client relationships. As a hands-on manager, Massimiliano, with his in-depth exerience and knowledge, is a resource for the whole clinical team, providing guidance and resolution on an ongoing basis, through frequent meetings and direct communication with the InnoPharma’s staff.

  • Clinical operations - management & monitoring

  • Marco Caimi – Project Management Director    

    Marco has a Bachelor Degree in Biology with a master in Biology applied to medical research and has solid clinical research experience of more than 15 years. With his experience, passion and attention, Marco supervises and coordinates the Clinical Project Manager team to ensure that sponsors are provided with the best scientific, regulatory and operational support. Through frequent meetings and contacts with his team, he ensures a proactive identification and quick management of projects’ risks and issues.

    Roberto Trabattoni – Clinical Monitoring Director           

    Roberto has a Bachelor Degree in Biotechnology with medical address, and with his extensive clinical experience in CRO environments he has spent the past 10 years as a Lead CRA/CRA Coordinator/Clinical Monitoring Director for InnoPharma. In this role, he successfully manages CRAs in both EU and non EU countries, overseeing the teams for all projects’ duration.

    As a young and talented Clinical Monitoring Director, he selects his team of CRAs, ensuring that productivity and competency levels are maximised and  that the training needs are satisfied, with constant attention to quality and timelines.

  • Regulatory & start up unit - PharmacoVigilance Unit

  • Alessandra Bertani – Regulatory Affairs Director              

    Alessandra is a certified biologist and has 30+ years of experience in healthcare settings, a master in Regulatory Affairs and has worked both in global pharmaceutical environment and CROs.

    Since the early 2000, she manages Innopharma’s Study Start-up and Regulatory team and oversights the submission phase for each study, with an extensive expertise in EU and non EU countries in each clinical study phase.

    Alessandra provides know-how and training to the regulatory team, and a constant update on new norms and regulations on clinical trials with drugs and devices.

    Through years of dedication, she has grown a passionate, supportive and hardworking team.

  • Quality Assurance

  • Carlotta Cozzi – Quality Assurance Manager    

    Carlotta has nearly 13 years of experience in clinical research and over 15 years of experience of quality management in accordance with GCP.

    She is Head of the Quality Assurance unit of InnoPharma. Quality Assurance Unit manages the Quality assurance system, Audit and Training activities in accordance with applicable regulations and GCPs.

    Carlotta works closely with other units to ensure their results are of a high standard.

Massimiliano Stasi, MD – General Manager, President and CEO

Massimiliano is a certified Medical Doctor and Surgeon in cardiology with 30+ years of clinical research experience in both pharmaceutical and CROs environments.

He has co-founded InnoPharma in 1995 and since 2006 he is owner and General Manager and he oversees all client relationships. As a hands-on manager, Massimiliano, with his in-depth exerience and knowledge, is a resource for the whole clinical team, providing guidance and resolution on an ongoing basis, through frequent meetings and direct communication with the InnoPharma’s staff.

Marco Caimi – Project Management Director    

Marco has a Bachelor Degree in Biology with a master in Biology applied to medical research and has solid clinical research experience of more than 15 years. With his experience, passion and attention, Marco supervises and coordinates the Clinical Project Manager team to ensure that sponsors are provided with the best scientific, regulatory and operational support. Through frequent meetings and contacts with his team, he ensures a proactive identification and quick management of projects’ risks and issues.

Roberto Trabattoni – Clinical Monitoring Director           

Roberto has a Bachelor Degree in Biotechnology with medical address, and with his extensive clinical experience in CRO environments he has spent the past 10 years as a Lead CRA/CRA Coordinator/Clinical Monitoring Director for InnoPharma. In this role, he successfully manages CRAs in both EU and non EU countries, overseeing the teams for all projects’ duration.

As a young and talented Clinical Monitoring Director, he selects his team of CRAs, ensuring that productivity and competency levels are maximised and  that the training needs are satisfied, with constant attention to quality and timelines.

Alessandra Bertani – Regulatory Affairs Director              

Alessandra is a certified biologist and has 30+ years of experience in healthcare settings, a master in Regulatory Affairs and has worked both in global pharmaceutical environment and CROs.

Since the early 2000, she manages Innopharma’s Study Start-up and Regulatory team and oversights the submission phase for each study, with an extensive expertise in EU and non EU countries in each clinical study phase.

Alessandra provides know-how and training to the regulatory team, and a constant update on new norms and regulations on clinical trials with drugs and devices.

Through years of dedication, she has grown a passionate, supportive and hardworking team.

Carlotta Cozzi – Quality Assurance Manager    

Carlotta has nearly 13 years of experience in clinical research and over 15 years of experience of quality management in accordance with GCP.

She is Head of the Quality Assurance unit of InnoPharma. Quality Assurance Unit manages the Quality assurance system, Audit and Training activities in accordance with applicable regulations and GCPs.

Carlotta works closely with other units to ensure their results are of a high standard.

Linkedin-in Mail-bulk

Credits